Literature DB >> 15378261

A case of antiphospholipid syndrome presenting with pulmonary truncus and main pulmonary artery thrombosis.

Mehmet Sayarlioglu1, Nazan Topcu, Mustafa Harman, Unal Guntekin, Reha Erkoc.   

Abstract

In patients with antiphospholipid syndrome (APS), thromboembolism and pulmonary hypertension are the most common pulmonary manifestations. Thrombotic obstruction at the level of the main and/or proximal pulmonary arteries is rare. We report a 40-year-old woman without any history of previous arterial and/or venous thrombosis who presented with severe dyspnea and was found to have pulmonary hypertension and positivity for anticardiolipin antibodies. Computed tomography revealed pulmonary truncus thrombosis extending to both right and left pulmonary arteries. The patient and her family refused surgical treatment. She had a prolonged hospital course, was unresponsive to thrombolytic, anticoagulant, antiplatelet, and immunosuppressive treatments, and died of right ventricle and respiratory failure 5 weeks later. This is the first reported case with thrombosis of pulmonary truncus and main pulmonary arteries concurrent with APS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15378261     DOI: 10.1007/s00296-004-0458-9

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  14 in total

1.  Guidelines on the investigation and management of the antiphospholipid syndrome.

Authors:  M Greaves; H Cohen; S J MacHin; I Mackie
Journal:  Br J Haematol       Date:  2000-06       Impact factor: 6.998

Review 2.  Antiphospholipid syndrome in SLE.

Authors:  M C Amigo; M A Khamashta; G R Hughes
Journal:  Baillieres Clin Rheumatol       Date:  1998-08

3.  Primary idiopathic pulmonary hypertension complicated by pulmonary arterial thrombosis. Association with antiphospholipid antibodies.

Authors:  M E Luchi; R A Asherson; R G Lahita
Journal:  Arthritis Rheum       Date:  1992-06

4.  Operation for chronic pulmonary thromboembolism accompanied by thrombophilia in 8 patients.

Authors:  M Ando; S Takamoto; Y Okita; R Matsukawa; N Nakanishi; S Kyotani; T Satoh
Journal:  Ann Thorac Surg       Date:  1998-12       Impact factor: 4.330

Review 5.  Antiphospholipid syndrome.

Authors:  J J Manson; D A Isenberg
Journal:  Int J Biochem Cell Biol       Date:  2003-07       Impact factor: 5.085

6.  Predictors of mortality in pulmonary thromboendarterectomy.

Authors:  R S Hartz; J G Byrne; S Levitsky; J Park; S Rich
Journal:  Ann Thorac Surg       Date:  1996-11       Impact factor: 4.330

Review 7.  [Pulmonary thromboendarterectomy in a patient with primary antiphospholipid syndrome].

Authors:  E Cucurull; J Ordi Ros; M Murtra; L Mellibovsky; R Orriols; M Vilardell
Journal:  Med Clin (Barc)       Date:  1996-04-06       Impact factor: 1.725

8.  Successful thromboendarterectomy for chronic pulmonary embolism in a patient with systemic lupus erythematosus and antiphospholipid syndrome.

Authors:  T Nakajima; H Ando; Y Ueno; H Umadome; Y Takahashi; Y Okano; S Takamoto
Journal:  Jpn Circ J       Date:  1997-11

9.  Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients.

Authors:  J L Vianna; M A Khamashta; J Ordi-Ros; J Font; R Cervera; A Lopez-Soto; C Tolosa; J Franz; A Selva; M Ingelmo
Journal:  Am J Med       Date:  1994-01       Impact factor: 4.965

10.  Primary antiphospholipid syndrome presenting as chronic thromboembolic pulmonary hypertension. Treatment with thromboendarterectomy.

Authors:  J Sandoval; M C Amigo; R Barragan; R Izaguirre; P A Reyes; M L Martinez-Guerra; A Palomar; A Gomez; R Garcia-Torres
Journal:  J Rheumatol       Date:  1996-04       Impact factor: 4.666

View more
  1 in total

1.  A 35-year-old man with dyspnea and hemoptysis.

Authors:  Ilad Alavi Darazam; Farid Azizi; Katayoon Najafizadeh; Davood Mansouri
Journal:  Tanaffos       Date:  2012
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.